Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2003
08/06/2003EP1332229A1 Method for screening agents capable of treating obesity
08/06/2003EP1332206A1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
08/06/2003EP1332149A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332142A1 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]b enzyl]thiazolidine-2,4-dione
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332132A2 Enamine derivatives as cell adhesion molecules
08/06/2003EP1332130A2 Atorvastatin hemi-calcium form vii
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
08/06/2003EP1331938A1 Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
08/06/2003EP1331937A2 Dibenzoxazepine alpha v integrin receptor antagonist
08/06/2003EP1331935A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
08/06/2003EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators
08/06/2003EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors
08/06/2003EP1176149B1 Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
08/06/2003EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i)
08/06/2003EP1077684B1 Effervescent preparations
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434830A 2-aminocarbonyl-9H-punine derivatives
08/06/2003CN1434828A Novel bisamidate phosphonate prodrugs
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434806A Substituted imidazole neuropeptide YY5 receptor antagonists
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434796A Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434725A Amphiphilic polymers and polypeptide conjugates comprising same
08/06/2003CN1434722A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434702A Novel forms of pravastatin sodium
08/06/2003CN1434681A Method for maintaining on improving the synthesis of mucins
08/06/2003CN1434053A Rhizoma anemarrhenae extract and preparation process and use thereof
08/06/2003CN1433799A Method for producing coated pill of health care products used for reducing weight and regulating blood-lipid
08/06/2003CN1433768A Flavone Hippophaes slow-released, control-redeased agent
08/06/2003CN1433766A Medicine for treating metabolism syndrome
08/06/2003CN1433712A Technological process for preparing beverage, oral liquor electuar, and antitoxic tablet from fern root
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/06/2003CN1116897C Parathyroid hormone medicine coposition
08/06/2003CN1116878C Nutrient for prevention and treatment of fatty liver caused by drinking wine and its mfg. method
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6603012 RAR selective retinoid agonists
08/05/2003US6602984 Human elastase IV
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003US6602901 Antidiabetic agents, obesity
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602857 Antisense modulation of PTP1B expression
08/05/2003US6602854 Branched multimeric Apo A-I agonist compounds
08/05/2003US6602296 Chemical supplementation of bone
07/2003
07/31/2003WO2003062821A1 Modulators of the clc-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states
07/31/2003WO2003062429A1 Novel serine protease
07/31/2003WO2003062427A1 Method of screening drug for improving insulin resistance
07/31/2003WO2003062405A2 Method for inducing differentiation of embryonic stem cells
07/31/2003WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
07/31/2003WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
07/31/2003WO2003062276A2 Multimers of receptor-binding ligands
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
07/31/2003WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
07/31/2003WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
07/31/2003WO2003062214A1 Novel stable crystal of benzylthiazolidinedione derivative and method for preparation thereof
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003062205A1 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
07/31/2003WO2003062186A1 Metal salts of (3s)-3-methoxycarbonyl-4-phenylbutyric acid and usage thereof
07/31/2003WO2003062182A1 Method for stabilizing reduced coenzyme q10 and composition therefor
07/31/2003WO2003061687A1 High-concentration preparation of soluble thrombomodulin
07/31/2003WO2003061682A1 The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus
07/31/2003WO2003061681A2 Proteins involved in the regulation of energy homeostasis and organelle metabolism
07/31/2003WO2003061673A1 Use of phosphorous dendrimers as medicaments.
07/31/2003WO2003061671A1 Amido macrolides
07/31/2003WO2003061667A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
07/31/2003WO2003061666A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
07/31/2003WO2003061663A1 Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia
07/31/2003WO2003061660A1 Melanocortin receptor agonists
07/31/2003WO2003061651A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
07/31/2003WO2003061650A1 Orodispersible pharmaceutical composition comprising mitiglinide
07/31/2003WO2003061648A1 Use of cholinesterase antagonists to treat insulin resistance
07/31/2003WO2003061647A1 Orodispersible pharmaceutical composition comprising 2-({2-methoxy-2- [3-(trifluoromethyl) phenyl]ethyl}amino) ethyl-4-(2-{ [2-(9h- fluoren-9-yl) acetyl]amino} ethyl)benzoate
07/31/2003WO2003061643A1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
07/31/2003WO2003061639A2 Use of glutathione synthesis stimulating compounds in reducing insulin resistance
07/31/2003WO2003061638A2 Use of phosphodiesterase antagonists to treat insulin resistance
07/31/2003WO2003061634A1 Sustained release pharmaceutical composition
07/31/2003WO2003061620A2 Peptide-carrying bodies for immune response
07/31/2003WO2003061604A2 Novel alkyl/aryl hydroxy or keto thiepines.
07/31/2003WO2003061593A2 Novel targeted compositions for diagnostic and therapeutic use
07/31/2003WO2003061566A2 Anti-cancer combination and use thereof
07/31/2003WO2003061551A2 Ex-vivo gene therapy of diabetes using iap polypeptides
1 ... 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 ... 1298